Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROSE Registry

Abstract Introduction Atopic dermatitis (AD) is a chronic, relapsing disease that can start at any age and has a significant negative impact on quality of life, including a significant itch burden. Here we report the proportion of patients in a real-world study achieving a complete/almost complete r...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Neal Bhatia, Charles W. Lynde, Luz Fonacier, Liyang Shao, Kwinten Bosman, Andrew Korotzer
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2025-04-01
coleção:	Dermatology and Therapy
Assuntos:	Atopic dermatitis Disease control Dupilumab Efficacy Patient-reported outcomes Real-world study
Acesso em linha:	https://doi.org/10.1007/s13555-025-01395-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!